EP3890776 - RECOMBINANT HIV ENV POLYPEPTIDES AND THEIR USES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 10.09.2021 Database last updated on 03.09.2024 | |
Former | The international publication has been made Status updated on 13.06.2020 | Most recent event Tooltip | 10.08.2024 | Change - representative | Applicant(s) | For all designated states International AIDS Vaccine Initiative 125 Broad Street, 9th Floor New York, NY 10004 / US | For all designated states The Scripps Research Institute 10550 North Torrey Pines Road La Jolla, CA 92037 / US | [2024/26] |
Former [2021/41] | For all designated states International AIDS Vaccine Initiative 125 Broad Street, 9th Floor New York, NY 10004 / US | ||
For all designated states The Scripps Research Institute 10550 North Torrey Pines Road La Jolla, CA 92037 / US | |||
For all designated states Burton, Dennis, R. C/o the Scripps Research Institute 10550 North Torrey Pines Road La Jolla CA 92037 / US | |||
For all designated states Andrabi, Raiees C/o International AIDS Vaccine Initiative 125 Broad Street 9th Floor New York NY 10004 / US | Inventor(s) | 01 /
BURTON, Dennis, R. c/o The Scripps Research Institute 10550 North Torrey Pines Road La Jolla, CA 92037 / US | 02 /
ANDRABI, Raiees c/o International AIDS Vaccine Initiative 125 Broad Street, 9th Floor New York, NY 10004 / US | [2021/41] | Representative(s) | Buzzi, Notaro & Antonielli d'Oulx S.p.A. Corso Vittorio Emmanuele II, 6 10123 Torino / IT | [N/P] |
Former [2021/41] | Freyria Fava, Cristina Buzzi, Notaro & Antonielli d'Oulx S.p.A. Corso Vittorio Emanuele ll, 6 10123 Torino / IT | Application number, filing date | 19892591.9 | 03.12.2019 | [2021/41] | WO2019US64138 | Priority number, date | US201862774693P | 03.12.2018 Original published format: US 201862774693 P | [2021/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020117740 | Date: | 11.06.2020 | Language: | EN | [2020/24] | Type: | A1 Application with search report | No.: | EP3890776 | Date: | 13.10.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.06.2020 takes the place of the publication of the European patent application. | [2021/41] | Search report(s) | International search report - published on: | US | 11.06.2020 | (Supplementary) European search report - dispatched on: | EP | 30.11.2022 | Classification | IPC: | A61K39/21 | [2021/41] | CPC: |
A61K39/12 (EP);
A61P31/18 (EP);
A61K2039/545 (EP);
A61K2039/55577 (EP);
A61K2039/575 (EP);
A61K2039/70 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/41] | Title | German: | REKOMBINANTE HIV-ENV-POLYPEPTIDE UND IHRE VERWENDUNGEN | [2021/41] | English: | RECOMBINANT HIV ENV POLYPEPTIDES AND THEIR USES | [2021/41] | French: | POLYPEPTIDES D'ENVELOPPE DU VIH RECOMBINÉS ET LEURS UTILISATIONS | [2021/41] | Entry into regional phase | 01.07.2021 | National basic fee paid | 01.07.2021 | Search fee paid | 01.07.2021 | Designation fee(s) paid | 01.07.2021 | Examination fee paid | Examination procedure | 03.06.2021 | Observations by third parties | 01.07.2021 | Examination requested [2021/41] | 23.06.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 16.12.2021 | Renewal fee patent year 03 | 27.12.2022 | Renewal fee patent year 04 | 27.12.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2011109511 (INT AIDS VACCINE INITIATIVE [US], et al) [X] 1,9,10,14 * figure 9c; claims 1,4 * [I] 12,13,15; | [XI]WO2013039792 (US HEALTH [US], et al) [X] 1-3,8-10 * page 40, line 33 - line 36 * * page 41, line 18 - line 29; table 1; sequence 8 * [I] 12-15; | [XI]WO2014043220 (UNIV CALIFORNIA [US]) [X] 1-3,8-10 * claims 1, 9; sequence 16 * [I] 12-15; | [X]WO2016037154 (US HEALTH [US]) [X] 1-3,5,7,12-15 * claims 1, 3, 6; sequence 745 *; | [XI]WO2017023857 (UNIV CALIFORNIA [US]) [X] 1-3,8-10 * figure 3 * [I] 12-15; | [XI] - JAMES E. VOSS ET AL, "Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model", CELL REPORTS, US, (20171001), vol. 21, no. 1, doi:10.1016/j.celrep.2017.09.024, ISSN 2211-1247, pages 222 - 235, XP055635632 [X] 1,5,7 * page 222, column right * * page 224, column right * * page 225, column left * [I] 12-15 DOI: http://dx.doi.org/10.1016/j.celrep.2017.09.024 | [A] - ANDRABI RAIEES ET AL, "Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design", IMMUNITY, CELL PRESS, AMSTERDAM, NL, (20151119), vol. 43, no. 5, doi:10.1016/J.IMMUNI.2015.10.014, ISSN 1074-7613, pages 959 - 973, XP029301066 [A] 1-3,5,7-10,12-15 * Summary * DOI: http://dx.doi.org/10.1016/j.immuni.2015.10.014 | [A] - ROGIER W. SANDERS ET AL, "A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies", PLOS PATHOGENS, (20130919), vol. 9, no. 9, doi:10.1371/journal.ppat.1003618, page e1003618, XP055131150 [A] 1-3,5,7-10,12-15 * the whole document * DOI: http://dx.doi.org/10.1371/journal.ppat.1003618 | International search | [XY] - CROOKS et al., "Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation", PLoS Pathog, (20180502), vol. 14, no. 5, pages 1 - 39, XP55714848 [X] 2, 12-14 * . Entire document, especially abstract; p. 2, para 1; p. 4, col 6; p. 17, col 1-3; p. 28, col 1; p. 32, col 3 * [Y] 1, 3 DOI: http://dx.doi.org/10.1371/journal.ppat.1007024 | [Y] - VOSS et al., "Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model", Cell Reports, (20171003), vol. 21, no. 1, doi:10.1016/j.celrep.2017.09.024, pages 222 - 235, XP055635632 [Y] 1, 3 * . Entire document, especially abstract; p. 231, col 2 to p. 232, col 1, para 1 * DOI: http://dx.doi.org/10.1016/j.celrep.2017.09.024 |